Evolution of concomitant use of veno-arterial extracorporeal membrane oxygenation support with Impella in cardiogenic shock: From percutaneous femoral Impella to axillary Impella 5.5.

Ameesh M Isath Suguru OhiraAvi LevineGregg M LanierStephen PanChhaya Aggarwal-GuptaIan MasonVasiliki GregoryDavid SpielvogelAlan L GassMasashi Kai

Published in: Artificial organs (2023)

Utilization of Impella 5.5 in the setting of ECPELLA provides greater hemodynamic support with a lower risk of complications compared to Impella CP or 2.5.

Keyphrases

extracorporeal membrane oxygenation
acute respiratory distress syndrome
respiratory failure
lymph node
ultrasound guided
mechanical ventilation
squamous cell carcinoma
minimally invasive
risk factors
left ventricular assist device
intensive care unit
early stage
sentinel lymph node
rectal cancer